I.V. Dressing Market
                     I.V. Dressing Market- Size, Share, Outlook, and Opportunity Analysis, 2020- 2027
I.V. is used for delivery of medication and fluid, blood transfusions, and others in
patients.  It  is  used  in  patients  for  fluid  replacement,  to  maintain  electrolyte
balance,  or  in  patients  with  physical  debility,  and  unconscious  patients.  I.V.
dressing  offers  quick  fixation  dressing  to  secure  I.V.  Cannula,  intramuscular
catheters,  and  other  percutaneous  devices  to  the  skin.  I.V.  dressing  are
transparent or translucent dressing made of adhesive material, and polyurethane
collated films, which prevents bacterial  infection at  the injection site and also
prevents moisture buildup to protect against dust and germs
Request  a  sample  copy  of  this  report:-  https://www.coherentmarketinsights.com/insight/request-
sample/3182 
Rising  incidences  of  infections  such  as  central  line  associated  bloodstream
infection  (CLABSI),  catheter-related  bloodstream infection  (CRBSI),  and other
infections  are expected to  boost  growth  of  the I.V.  dressing  market  over  the
forecast  period.  For  instance,  according  to  the  data  published  in  National
Healthcare Safety Network Bloodstream Infection Surveillance in March 2018,
around 30,000 CLABSI cases are reported every year in the U.S. CLABSI can
prolong the hospital stay, which can increase the cost burden on patients and
also may lead to mortality.
Furthermore,  according  to  the  International  Society  for  Infectious  Diseases,
March 2018, around 250,000 cases of blood stream are reported every year in
the U.S. among these, around 80,000 are catheter-related bloodstream infection
(CRBSI), which occurs in intensive care units.
North America accounted for the largest market share in 2018, owing to launches
and  approvals  of  new  I.V.  dressing  products  in  the  region.  For  instance,  in
January 2016, Entrotech life sciences, a U.S.-based company, received 510(k)
clearance from the U.S. Food and Drug Administration (FDA) for ChloraDerm
dressing,  which  protects  against  multi-drug-resistant  organisms  and  other
catheter-related bloodstream infections. Moreover, in September 2016, Becton,
Dickinson  and  Company  and  Vancive  Medical  Technologies  entered  into  a
collaboration  to  launch  a  line  of  ChloraShield  I.V.  dressings  developed  for
vascular access dressing and enhancing patient care. Therefore, these factors
are expected to boost growth of the global I.V. dressing market over the forecast
period.
Key  players  operating  in  the  global  I.V.  dressing  market  include  Medline
Industries, 3M, Paul Hartmann AG, Deroyal, Tytex Inc., Reliamed, Acelity, BSN
Medical,  CareFusion,  Lohmann  &  Rauscher,  Smith  &  Nephew,  Shandong
Dermcosy  Medical  Co.,Ltd.,  Talent  Health  Care,  Datt  Mediproducts  Private
Limited, and Others.
Moreover, key players in the market are focused on developing new products, in
order  to  enhance  their  market  share.  For  instance,  in  2015,  3M  launched
Tegaderm CHG Chlorhexidine Gluconate I.V. port dressing for the patients with
port devices under the skin, who are connected to catheter for central venous
infusion.
Get the main link:-  https://www.coherentmarketinsights.com/ongoing-insight/iv-dressing-market-3182 
Contact Us:
Mr. Shah
Coherent Market Insights
1001 4th Ave, #3200
Seattle, WA 98154
Tel: +1-206-701-6702
Email: [email protected]
Visit our news Website: http://www.coherentchronicle.com/